Susceptibility of Schistosoma mansoni from Liberia and Puerto Rico to antischistosomal drugs.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006824:Hybridization, Genetic / Q000187:drug effects; D007988:Liberia; D008154:Lucanthone / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009581:Nitrofurans / Q000494:pharmacology / Q000627:therapeutic use; D010069:Oxadiazoles / Q000494:pharmacology / Q000627:therapeutic use; D011647:Puerto Rico; D012550:Schistosoma mansoni / Q000187:drug effects*; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000494:pharmacology / Q000627:therapeutic use; D014753:Vinyl Compounds / Q000494:pharmacology / Q000627:therapeutic use
D000871:Anthelmintics; D001557:Benzenesulfonates; D009581:Nitrofurans; D010069:Oxadiazoles; D012556:Schistosomicides; D014753:Vinyl Compounds; D008154:Lucanthone